ECMedical LLC

North Huntingdon, PA · Biotech

Implantable tissue-engineered pancreatic organoids using porcine cells in extracellular matrix hydrogel, genetically engineered to prevent rejection and provide autonomous glucose control

Grants
$225K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase I · Genetically Engineered Pancreatic Organoids Composed of Extracellular Matrix Hydrogels for the Purpose of Long-Term Therapeutic Glycemic Maintenance$224,589
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3036Surface Oncology——
3037OPSIN BIOTHERAPEUTICS INC.——
3038TRANSIRA THERAPEUTICS LLC——
3039ECMedical LLC——
3040GENETOBE INC——
3041DISCOVERY GENOMICS, INC.——
3042TOPOGENE, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.